MultiTarget Pharmaceuticals LLC

Sam Walton's Wisdom on Customer:

There is only one boss - the customer. He can fire everybody in the company, from the chairman on down, simply by spending his money somewhere else.



MultiTarget Pharmaceuticals LLC will provide its news and updates in this newsroom. Thank you for your interest in following our growth and development

(No update is currently available)

 MultiTarget Pharmaceuticals LLC introduced its third multifunctional reagent product, AquaRNA, for the isolation and purification of total RNA. Due to its ability to inactivate and remove  RNases inside RNA samples, AquaRNA could become a coveted tool for RNA research.

 MultiTarget Pharmaceuticals LLC and Inflabloc Pharmaceuticals Inc have signed a collaborative research agreement to use MultiTarget's Bioenhancer to enhance the uptake and activity of Inflabloc's novel anti-cancer agent for the treatment of colorectal cancers.

04/17/2007 MultiTarget Pharmaceuticals LLC's AquaPlasmid and AquaGenomic innovation was named one of the three finalists for the 2007 Utah Innovation Awards in Biotechnology and Pharmaceuticals.

09/01/2006  MultiTarget Pharmaceuticals LLC was awarded a Small Business Innovation Research (SBIR) grant from the National Institute of Health (NIH) to develop multitarget inhibitors as potential oral drug bioenhancers.

09/01/2005  MultiTarget Pharmaceuticals LLC introduced its second multifunctional reagent product, AquaGenomic, for the isolation and purification of genomic DNA. 

06/01/2005  MultiTarget Pharmaceuticals LLC introduced its first multifunctional reagent product, AquaPlasmid, for the isolation and purification of plasmid DNA. 

11/30/2004  MultiTarget Pharmaceuticals LLC was established in Salt Lake City, Utah, to explore the potentials of molecules with multiple functionalities.